GE Healthcare announced today that it executed a master research agreement with ImaginAb Inc. for the development of new positron emission tomography (PET) diagnostic imaging agents for cardiovascular diseases.
ImaginAb, founded in 2007 by UCLA faculty, is a biotechnology company specialized in diagnostic imaging and applications with a focused pipeline toward cancer and immunology.